Figure
2
References:
- Coskun A, Balbay O, Duran S, Annakkaya AN, Bulut I, Yavuz O, et al.
Pregnancy-associated plasma protein-A and asthma. Adv Ther.
2007;24(2):362-7.
- Bulut I, Ozseker ZF, Coskun A, Serteser M, Unsal I.
Pregnancy-associated plasma protein-A (PAPP-A) levels in patients with
severe allergic asthma are reduced by omalizumab. J Asthma.
2018;55(10):1116-21.
- Pavlidis S, Takahashi K, Ng Kee Kwong F, Xie J, Hoda U, Sun K, et al.
”T2-high” in severe asthma related to blood eosinophil, exhaled nitric
oxide and serum periostin. Eur Respir J. 2019;53(1).
- Shaw DE, Sousa AR, Fowler SJ, Fleming LJ, Roberts G, Corfield J, et
al. Clinical and inflammatory characteristics of the European
U-BIOPRED adult severe asthma cohort. Eur Respir J.
2015;46(5):1308-21.
- Kuo CS, Pavlidis S, Loza M, Baribaud F, Rowe A, Pandis I, et al. A
Transcriptome-driven Analysis of Epithelial Brushings and Bronchial
Biopsies to Define Asthma Phenotypes in U-BIOPRED. Am J Respir Crit
Care Med. 2017;195(4):443-55.
- Silkoff PE, Strambu I, Laviolette M, Singh D, FitzGerald JM, Lam S, et
al. Asthma characteristics and biomarkers from the Airways Disease
Endotyping for Personalized Therapeutics (ADEPT) longitudinal
profiling study. Respiratory research. 2015;16:142.